 |
| USCRM™ is cryopreserved umbilical cord blood stem cells for implantation. USCRM™ is performed by three stages: harvesting stem cells from umbilical cord of placenta at birth, cryopreserving stem cell for more than 15 years in Stem cell Processing Center, implanting stem cells into patient. |
 |
| Application |
| Restoring blood and immune system |
 |
Malignancies |
|
Child with leukemia |
|
Sickle cell anemia. |
|
Combined immunodeficiency Slowing the progressive brain damage |
|
Sanfilippo Syndrome |
|
Krabbe Disease |
|
Hurler's Syndrome |
|
| Composition |
| USCRM™ (Cryopreserved cord blood stem cell) |
|
360 million total nucleated cells in 25ml / 1 bag |
|
| Procedure |
|
Harvesting cord blood from umbilical cord at birth |
|
Isolation of nucleated cells from the cord blood |
|
Cryopreservation for more than 15 years |
|
| How to use & Dosage |
|
USCRM™ can be implanted with SurgiFill™, DuoFill™, fibrin glue and Theraform™ |
|
|
 |
| Advantages of cord blood over bone marrow as a source of stem cells |
|
Can be used without a perfect genetic match |
|
Less acute graft-versus-host disease (GVHD) |
|
Free from viruses such as cytomegalovirus |
|
Clonogenic lymphoid progenitor with both B cell and natural killer cell lineage |
|
More primitive developmental stage |
|
More complete clinical immune recovery |
|
